Tom Hooven is a physician-scientist in the Division of Neonatal-Perinatal Medicine at Columbia University Medical Center. In addition to caring for critically ill newborns and infants in the neonatal ICU at Morgan Stanley Children's Hospital of New York-Presbyterian, he performs microbiology and infectious diseases research at New York University's Langone Medical Center. His research focuses on group B streptococcus, a bacteria that causes life-threatening infections among newborns, particularly those born prematurely. He uses bacterial genomic analysis to identify potential drug or vaccine targets that might help eradicate group B streptococcus.
Premature Babies Are Struggling to Breathe. Why Are Regulators Dragging Their Feet?
More automation in health care could save lives, but progress is too slow.
